Study time

2015.1-2015.12

Country

China

Object

patients with prostatic adenocarcinoma who underwent RP between 1 January 2015 and 31 December 2015. Other inclusion criteria were age ≥ 20 years, American Joint Committee on Cancer (AJCC) pathologic T1–T4 without distant metastasis, and AJCC clinical T1-4N0. 

Inclusion criteria

history of cancer before PC diagnosis, unknown clinical or pathologic stage, unknown D’Amico risk classification, unknown ISUP grade group, missing preoperative PSA data, clinical or pathologic lymph node-positive findings, unclear margin status, and nodenocarcinoma histology

Robots remarks

RARP

Sample size

1407

Topic classification

Hospital

Keypoint

Hospital volume significantly affected PSM and biochemical-failure-free survival in robotic RP, but not in nonrobotic RP. When patients with PC want to receive robotic RP, it should be performed in a relatively high-volume hospital (>100 patients/year).

Year